Surufatinib or Surufatinib Combined With Vinorelbine for Non-Small Cell Lung Cancer
Affiliated Cancer Hospital & Institute of Guangzhou Medical University
Affiliated Cancer Hospital & Institute of Guangzhou Medical University
Second Affiliated Hospital of Soochow University
Betta Pharmaceuticals Co., Ltd.
Shanghai Chest Hospital
Sungkyunkwan University
International Group of Endovascular Oncology
Shenzhen People's Hospital
Xinqiao Hospital of Chongqing
Tianjin Medical University Cancer Institute and Hospital
Betta Pharmaceuticals Co., Ltd.
IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy
Seoul National University Hospital
Hebei Medical University Fourth Hospital
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Peking Union Medical College Hospital
Peking Union Medical College Hospital
Chinese Lung Cancer Surgical Group
National Cancer Institute (NCI)
National Cancer Institute (NCI)
LungenClinic Grosshansdorf
Charite University, Berlin, Germany
Inje University